RVLP
Vanguard Group’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-246,353
| Closed | -$21.3K | – | 4578 |
|
|
2023
Q3 | $21.3K | Hold |
246,353
| – | – | ﹤0.01% | 4492 |
|
|
2023
Q2 | $138K | Hold |
246,353
| – | – | ﹤0.01% | 4363 |
|
|
2023
Q1 | $281K | Hold |
246,353
| – | – | ﹤0.01% | 4266 |
|
|
2022
Q4 | $276K | Buy |
246,353
+23,918
| +11% | +$26.8K | ﹤0.01% | 4242 |
|
|
2022
Q3 | $467K | Hold |
222,435
| – | – | ﹤0.01% | 4231 |
|
|
2022
Q2 | $302K | Buy |
222,435
+14,493
| +7% | +$19.7K | ﹤0.01% | 4407 |
|
|
2022
Q1 | $352K | Hold |
207,942
| – | – | ﹤0.01% | 4447 |
|
|
2021
Q4 | $225K | Sell |
207,942
-2,492
| -1% | -$2.7K | ﹤0.01% | 4545 |
|
|
2021
Q3 | $621K | Hold |
210,434
| – | – | ﹤0.01% | 4346 |
|
|
2021
Q2 | $634K | Sell |
210,434
-57,973
| -22% | -$175K | ﹤0.01% | 4232 |
|
|
2021
Q1 | $875K | Buy |
268,407
+7,197
| +3% | +$23.5K | ﹤0.01% | 4043 |
|
|
2020
Q4 | $1.08M | Buy |
261,210
+6,786
| +3% | +$28K | ﹤0.01% | 3810 |
|
|
2020
Q3 | $1.38M | Buy |
254,424
+309
| +0.1% | +$1.67K | ﹤0.01% | 3587 |
|
|
2020
Q2 | $1.71M | Buy |
254,115
+27,824
| +12% | +$187K | ﹤0.01% | 3473 |
|
|
2020
Q1 | $719K | Buy |
226,291
+120,259
| +113% | +$382K | ﹤0.01% | 3584 |
|
|
2019
Q4 | $741K | Buy |
106,032
+664
| +0.6% | +$4.64K | ﹤0.01% | 3704 |
|
|
2019
Q3 | $405K | Sell |
105,368
-16,231
| -13% | -$62.4K | ﹤0.01% | 3859 |
|
|
2019
Q2 | $462K | Sell |
121,599
-222
| -0.2% | -$843 | ﹤0.01% | 3840 |
|
|
2019
Q1 | $438K | Buy |
121,821
+8,137
| +7% | +$29.3K | ﹤0.01% | 3796 |
|
|
2018
Q4 | $881K | Buy |
+113,684
| New | +$881K | ﹤0.01% | 3597 |
|